서울대학교 중앙도서관
S-Space 소개
My S-Space
로그인이 필요합니다.
Login

S-Space

Browse

Author

Jump to a point in the index
Or type in a year

  • Sort by
  • In order
  • Results/Page
  • Authors/record

Showing results 1 to 14 of 14

Issue DateTitle / Author(s) / CitationFileAltmetrics
2012-10
Poor correlation between tuberculin skin tests and interferon-gamma assays in close contacts of patients with multidrug-resistant tuberculosis
DOI
2019-01
Delamanid, linezolid, levofloxacin, and pyrazinamide for the treatment of patients with fluoroquinolone-sensitive multidrug-resistant tuberculosis (Treatment Shortening of MDR-TB Using Existing and New Drugs, MDR-END): study protocol for a phase II/III, multicenter, randomized, open-label clinical trial
DOI
2019-01
Delamanid, linezolid, levofloxacin, and pyrazinamide for the treatment of patients with fluoroquinolone-sensitive multidrug-resistant tuberculosis (Treatment Shortening of MDR-TB Using Existing and New Drugs, MDR-END): study protocol for a phase II/III, multicenter, randomized, open-label clinical trial
view fileDOI
2019-12
Early discontinuation of ethambutol in pulmonary tuberculosis treatment based on results of the GenoType MTBDRPlus assay: A prospective, multicenter, noninferiority randomized trial in South Korea
DOI
2020-01
Extracorporeal membrane oxygenation as a bridge to lung transplantation: analysis of Korean organ transplantation registry (KOTRY) data
view filelink
2020-04
Protocol of a Nationwide Observational Study among Patients with Nontuberculous Mycobacterium Pulmonary Disease in South Korea (NTM-KOREA)
DOI
2020-06
Interim treatment outcomes in multidrug-resistant tuberculosis using bedaquiline and/or delamanid in South Korea

Kang, Hyungseok; Jo, Kyung-Wook; Jeon, Doosoo; Yim, Jae-Joon; Shim, Tae Sun

Respiratory Medicine, Vol.167, p. 105956

DOI
2020-09
Interim treatment outcomes in multidrug-resistant tuberculosis patients treated sequentially with bedaquiline and delamanid

Lee, Hoon Hee; Jo, Kyung-Wook; Yim, Jae-Joon; Jeon, Doosoo; Kang, Hyungseok; Shim, Tae Sun

International Journal of Infectious Diseases, Vol.98, pp.478-485

DOI
2021-06
Impact of Susceptibility to Injectable Antibiotics on the Treatment Outcomes of Mycobacterium abscessus Pulmonary Disease
DOI
2021-06
Prediction of 1-year treatment outcome using early sputum culture conversion status in Mycobacterium abscessus pulmonary disease
DOI
2022-08
Treatment outcomes of multidrug-resistant tuberculosis with chronic kidney/liver disease

Jo, Kyung-Wook; Shim, Tae Sun; Chung, Chiwook; Shin, Jung Eun; Jeon, Doosoo; Kang, Hyungseok; Yim, Jae-Joon

European Respiratory Journal, Vol.60 No.2, p. 2200930

DOI
2022-08
Treatment outcome of continuation of intravenous amikacin for Mycobacterium abscessus pulmonary disease with a persistent culture positivity after the treatment initiation
DOI
2022-10
9 months of delamanid, linezolid, levofloxacin, and pyrazinamide versus conventional therapy for treatment of fluoroquinolone-sensitive multidrug-resistant tuberculosis (MDR-END): a multicentre, randomised, open-label phase 2/3 non-inferiority trial in South Korea
DOI
2024-04
Improvement in Health-Related Quality of Life Following Antibiotic Treatment in Nontuberculous Mycobacterial Pulmonary Disease: Initial Analysis of the NTM-KOREA Cohort
DOI
1